EE200000308A - Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid - Google Patents

Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid

Info

Publication number
EE200000308A
EE200000308A EEP200000308A EEP200000308A EE200000308A EE 200000308 A EE200000308 A EE 200000308A EE P200000308 A EEP200000308 A EE P200000308A EE P200000308 A EEP200000308 A EE P200000308A EE 200000308 A EE200000308 A EE 200000308A
Authority
EE
Estonia
Prior art keywords
protein
methods
hydrophobic moiety
hydrophobically modified
modified protein
Prior art date
Application number
EEP200000308A
Other languages
English (en)
Estonian (et)
Inventor
Pepinsky R. Blake
Zeng Chenhui
P. Baker Darren
Wen Dingyi
P. Williams Kevin
A. Garber Ellen
L. Strauch Kathryn
R. Taylor Frederick
H. Weinrub Paul
C. Petter Russell
Galdes Alphonse
Porter Jeffrey
Original Assignee
Biogen, Inc.
Ontogeny, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Inc., Ontogeny, Inc. filed Critical Biogen, Inc.
Publication of EE200000308A publication Critical patent/EE200000308A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Graft Or Block Polymers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200000308A 1997-12-03 1998-12-03 Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid EE200000308A (et)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6742397P 1997-12-03 1997-12-03
US7893598P 1998-03-20 1998-03-20
US8968598P 1998-06-17 1998-06-17
US9980098P 1998-09-10 1998-09-10
PCT/US1998/025676 WO1999028343A2 (en) 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods

Publications (1)

Publication Number Publication Date
EE200000308A true EE200000308A (et) 2001-10-15

Family

ID=27490628

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000308A EE200000308A (et) 1997-12-03 1998-12-03 Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid

Country Status (25)

Country Link
US (1) US6444793B1 (no)
EP (1) EP1036092B1 (no)
JP (1) JP4289788B2 (no)
KR (1) KR20010032753A (no)
CN (1) CN1294595A (no)
AT (1) ATE295372T1 (no)
AU (1) AU757497B2 (no)
BR (1) BR9815142A (no)
CA (1) CA2309806A1 (no)
CZ (1) CZ20002008A3 (no)
DE (1) DE69830192T2 (no)
DK (1) DK1036092T3 (no)
EA (1) EA003739B1 (no)
EE (1) EE200000308A (no)
ES (1) ES2243018T3 (no)
HU (1) HUP0100535A3 (no)
IL (2) IL136137A0 (no)
IS (1) IS2163B (no)
MX (1) MXPA00005494A (no)
NO (1) NO20002789L (no)
NZ (1) NZ504752A (no)
PL (1) PL197833B1 (no)
PT (1) PT1036092E (no)
TR (1) TR200001612T2 (no)
WO (1) WO1999028343A2 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034269A1 (en) * 1997-11-28 2000-09-13 Roche Diagnostics GmbH An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
KR20010032753A (ko) 1997-12-03 2001-04-25 온토제니, 인코오포레이티드 소수적으로 개질된 단백질 조성물 및 방법
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP0953576B1 (en) * 1998-04-30 2005-11-02 Curis, Inc. Active hedgehog protein conjugate, process for its production and use
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
ATE404583T1 (de) * 1998-11-02 2008-08-15 Curis Inc Funktionelle antagonisten von hedgehog-aktivität
IL143403A0 (en) * 1998-12-03 2002-04-21 Biogen Inc Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
JP2003502292A (ja) * 1999-06-01 2003-01-21 バイオジェン インコーポレイテッド ヘッジホッグタンパク質のポリマー結合体及び利用
AU2005203058C1 (en) * 1999-11-05 2009-07-02 Curis, Inc. Hedgehog fusion proteins and uses
AU780693B2 (en) * 1999-11-05 2005-04-14 Curis, Inc. Hedgehog fusion proteins and uses
WO2001082994A1 (en) * 2000-04-28 2001-11-08 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
AU2003225085A1 (en) * 2002-04-19 2003-11-03 California Institute Of Technology Unnatural amino acid containing display libraries
JP2008506703A (ja) 2004-07-14 2008-03-06 ユニバーシティ オブ ユタ リサーチ ファウンデーション ネトリン関連化合物および用途
WO2006101273A1 (ja) * 2005-03-25 2006-09-28 Takeda Pharmaceutical Company Limited 癌の予防・治療剤
AU2006313464B2 (en) * 2005-11-11 2012-07-12 Proteogen Bio S.R.L. Method of converting water-soluble active proteins into hydrophobic active proteins, the use of the same for the preparation of monomolecular layers of oriented active proteins, and devices comprising the same
US8273747B2 (en) 2006-11-02 2012-09-25 Curis, Inc. Small organic molecule regulators of cell proliferation
KR100876657B1 (ko) * 2007-10-15 2009-01-07 한국기계연구원 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법
CN101952306B (zh) * 2008-02-21 2014-09-10 皮护神经科学协会 Mntf肽的化妆和皮肤病制剂
US20100316566A1 (en) * 2008-02-27 2010-12-16 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CN103665095A (zh) * 2012-09-11 2014-03-26 中国人民解放军军事医学科学院卫生学环境医学研究所 一种疏水性多肽修饰抗体的合成方法
CN106924754B (zh) * 2015-12-30 2021-11-09 北京大学 聚氨基酸偶联物
CN108147990B (zh) * 2016-12-02 2023-01-24 上海中医药大学 一种膜锚定元件及其应用
KR102710762B1 (ko) 2017-10-25 2024-09-25 얀센 파마슈티칼즈, 인코포레이티드 인산화 타우 펩티드의 조성물 및 이의 용도
AU2020219804A1 (en) 2019-02-08 2021-08-19 Ac Immune S.A. Method of safe administration of phosphorylated Tau peptide vaccine
JP2023136614A (ja) * 2022-03-17 2023-09-29 三菱ケミカル株式会社 植物を用いたヘッジホッグタンパク質の製造方法
CN116983461B (zh) * 2023-03-14 2025-07-22 中国石油大学(华东) 基于脂质体修饰的止血海绵体系
CN116549713B (zh) * 2023-05-09 2025-06-13 浙江大学 一种兼具组织粘合和防粘连的手术贴片和其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
EP0966478A4 (en) * 1996-10-07 2002-08-21 Univ Johns Hopkins Med Novel hedgehog-derived polypeptides
KR20010032753A (ko) 1997-12-03 2001-04-25 온토제니, 인코오포레이티드 소수적으로 개질된 단백질 조성물 및 방법

Also Published As

Publication number Publication date
DE69830192T2 (de) 2006-01-12
KR20010032753A (ko) 2001-04-25
AU1996699A (en) 1999-06-16
IL136137A0 (en) 2001-05-20
WO1999028343A9 (en) 1999-10-14
HUP0100535A2 (hu) 2001-06-28
EA200000605A1 (ru) 2000-12-25
JP2001525336A (ja) 2001-12-11
TR200001612T2 (tr) 2001-01-22
WO1999028343A3 (en) 1999-08-12
IL136137A (en) 2009-09-22
DE69830192D1 (de) 2005-06-16
BR9815142A (pt) 2000-10-10
WO1999028343A2 (en) 1999-06-10
JP4289788B2 (ja) 2009-07-01
CN1294595A (zh) 2001-05-09
EP1036092B1 (en) 2005-05-11
HK1030953A1 (en) 2001-05-25
PL197833B1 (pl) 2008-04-30
US6444793B1 (en) 2002-09-03
EP1036092A2 (en) 2000-09-20
PT1036092E (pt) 2005-09-30
PL341430A1 (en) 2001-04-09
IS2163B (is) 2006-11-15
CZ20002008A3 (cs) 2001-11-14
ES2243018T3 (es) 2005-11-16
NO20002789D0 (no) 2000-05-31
IS5499A (is) 2000-05-15
NZ504752A (en) 2002-10-25
EA003739B1 (ru) 2003-08-28
CA2309806A1 (en) 1999-06-10
MXPA00005494A (es) 2003-05-19
ATE295372T1 (de) 2005-05-15
NO20002789L (no) 2000-08-02
HUP0100535A3 (en) 2003-09-29
AU757497B2 (en) 2003-02-20
DK1036092T3 (da) 2005-08-15

Similar Documents

Publication Publication Date Title
EE200000308A (et) Hüdrofoobselt modifitseeritud valgu kompositsioonid ja meetodid
De Caro et al. Porcine pancreatic lipase. Completion of the primary structure
Kuhn et al. The cytoplasmic carboxy terminus of M13 procoat is required for the membrane insertion of its central domain
PT1309861E (pt) Arrays funcionais de proteinas
DE60144145D1 (de) Subtilisin-variante
EP1067182A3 (en) Secretory protein or membrane protein
CY1111006T1 (el) Εκριμματαση ασθενειας alzheimer
BR9811675A (pt) Genes isolados para proteìna da membrana de célula dentrìtica
ATE219380T1 (de) Vehikel zum einbringen von nukleinsäuren in zellen
ATE532533T1 (de) Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen
Takishima et al. Amino acid sequences of two nonspecific lipid‐transfer proteins from germinated castor bean
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
BR9913076A (pt) Método para melhorar nìveis de expressão de uma ou mais proteìnas em um vegetal transgênico, e para a expressão de proteìnas múltiplas em um vegetal transgênico, uso de um propeptìdeo clivável no caminho secretor de um ligador vegetal, e como um ligador clivável em precusores de poliproteìna sintetizados por intermédio do caminho secretor em vegetais transgênicos, uso em uma sequência de propeptìdeo rica nos aminoácidos pequenos a, v, s e t e contendo sequências dipeptìdicas consistindo de dois resìduos ácidos, dois resìduos básicos ou um resìduo ácido e um básico como uma sequência ligadora clivável, construção de dna, vetor, vegetal transgênico, uso de uma construção de dna, e, ácido nucleico
Harnett et al. Molecular cloning and demonstration of an aminopeptidase activity in a filarial nematode glycoprotein
WO1999028876A3 (en) Hydrophobically-modified protein compositions and methods
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
BR9811334A (pt) Processo para preparação e/ou purificação de amido ácido fenil éster sulfonatos
CY1105486T1 (el) Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων
Bell et al. In vivo NH2-terminal acetylation of Sindbis virus proteins.
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
BR9713632A (pt) Citocina de mamìfero relacionada com a il-10
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2002012541A3 (en) Novel motor proteins and methods for their use
DE69837562D1 (de) Peptidstrukturen und deren anwendung in der diagnostik von herpes simplex virus typ 2